Copyright Reports & Markets. All rights reserved.

Global In-Vitro Colorectal Cancer Screening Tests Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biomarker Tests
      • 1.4.3 Fecal Occult Blood Tests
      • 1.4.4 CRC DNA Screening Tests
    • 1.5 Market by Application
      • 1.5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2014-2025)
      • 1.5.2 Hospital & Clinics
      • 1.5.3 Ambulatory
      • 1.5.4 Home Care
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 In-Vitro Colorectal Cancer Screening Tests Market Size
    • 2.2 In-Vitro Colorectal Cancer Screening Tests Growth Trends by Regions
      • 2.2.1 In-Vitro Colorectal Cancer Screening Tests Market Size by Regions (2014-2025)
      • 2.2.2 In-Vitro Colorectal Cancer Screening Tests Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 In-Vitro Colorectal Cancer Screening Tests Market Size by Manufacturers
      • 3.1.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
    • 3.2 In-Vitro Colorectal Cancer Screening Tests Key Players Head office and Area Served
    • 3.3 Key Players In-Vitro Colorectal Cancer Screening Tests Product/Solution/Service
    • 3.4 Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2014-2019)
    • 4.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 5.2 In-Vitro Colorectal Cancer Screening Tests Key Players in United States
    • 5.3 United States In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 5.4 United States In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    6 Europe

    • 6.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 6.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Europe
    • 6.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 6.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    7 China

    • 7.1 China In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 7.2 In-Vitro Colorectal Cancer Screening Tests Key Players in China
    • 7.3 China In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 7.4 China In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    8 Japan

    • 8.1 Japan In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 8.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Japan
    • 8.3 Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 8.4 Japan In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 9.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Southeast Asia
    • 9.3 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 9.4 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    10 India

    • 10.1 India In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 10.2 In-Vitro Colorectal Cancer Screening Tests Key Players in India
    • 10.3 India In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 10.4 India In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    11 Central & South America

    • 11.1 Central & South America In-Vitro Colorectal Cancer Screening Tests Market Size (2014-2019)
    • 11.2 In-Vitro Colorectal Cancer Screening Tests Key Players in Central & South America
    • 11.3 Central & South America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
    • 11.4 Central & South America In-Vitro Colorectal Cancer Screening Tests Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Molecular
      • 12.1.1 Abbott Molecular Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.1.4 Abbott Molecular Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.1.5 Abbott Molecular Recent Development
    • 12.2 Beckman Coulter
      • 12.2.1 Beckman Coulter Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.2.4 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.2.5 Beckman Coulter Recent Development
    • 12.3 Alere
      • 12.3.1 Alere Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.3.4 Alere Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.3.5 Alere Recent Development
    • 12.4 Epigenomics
      • 12.4.1 Epigenomics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.4.4 Epigenomics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.4.5 Epigenomics Recent Development
    • 12.5 Eiken Chemical
      • 12.5.1 Eiken Chemical Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.5.4 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.5.5 Eiken Chemical Recent Development
    • 12.6 Sysmex
      • 12.6.1 Sysmex Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.6.4 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.6.5 Sysmex Recent Development
    • 12.7 Siemens Healthcare
      • 12.7.1 Siemens Healthcare Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.7.4 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.7.5 Siemens Healthcare Recent Development
    • 12.8 Quest Diagnostics
      • 12.8.1 Quest Diagnostics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.8.4 Quest Diagnostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.8.5 Quest Diagnostics Recent Development
    • 12.9 Companion Dx
      • 12.9.1 Companion Dx Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.9.4 Companion Dx Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.9.5 Companion Dx Recent Development
    • 12.10 Oncocyte
      • 12.10.1 Oncocyte Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 In-Vitro Colorectal Cancer Screening Tests Introduction
      • 12.10.4 Oncocyte Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2014-2019)
      • 12.10.5 Oncocyte Recent Development
    • 12.11 Merck Millipore
    • 12.12 Immunostics
    • 12.13 ExiQon
    • 12.14 Kyowa Medex
    • 12.15 Mode Diagnostics
    • 12.16 Randox Laboratories
    • 12.17 R-Biopharm

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
      Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal cancer screening tests market over the forecast period.
      In 2018, the global In-Vitro Colorectal Cancer Screening Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global In-Vitro Colorectal Cancer Screening Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In-Vitro Colorectal Cancer Screening Tests development in United States, Europe and China.

      The key players covered in this study
      Abbott Molecular
      Beckman Coulter
      Alere
      Epigenomics
      Eiken Chemical
      Sysmex
      Siemens Healthcare
      Quest Diagnostics
      Companion Dx
      Oncocyte
      Merck Millipore
      Immunostics
      ExiQon
      Kyowa Medex
      Mode Diagnostics
      Randox Laboratories
      R-Biopharm

      Market segment by Type, the product can be split into
      Biomarker Tests
      Fecal Occult Blood Tests
      CRC DNA Screening Tests

      Market segment by Application, split into
      Hospital & Clinics
      Ambulatory
      Home Care

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global In-Vitro Colorectal Cancer Screening Tests status, future forecast, growth opportunity, key market and key players.
      To present the In-Vitro Colorectal Cancer Screening Tests development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of In-Vitro Colorectal Cancer Screening Tests are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now